These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
223 related items for PubMed ID: 21879400
21. Separation of advanced from mild hepatic fibrosis by quantification of the hepatobiliary uptake of Gd-EOB-DTPA. Norén B, Forsgren MF, Dahlqvist Leinhard O, Dahlström N, Kihlberg J, Romu T, Kechagias S, Almer S, Smedby Ö, Lundberg P. Eur Radiol; 2013 Jan; 23(1):174-81. PubMed ID: 22836161 [Abstract] [Full Text] [Related]
22. The hepatocyte phase of Gd-EOB-DTPA-enhanced MRI in the evaluation of hepatic fibrosis and early liver cirrhosis in a rat model: an experimental study. Ma C, Liu A, Wang Y, Geng X, Hao L, Song Q, Sun B, Wang H, Zhao G. Life Sci; 2014 Jul 17; 108(2):104-8. PubMed ID: 24881519 [Abstract] [Full Text] [Related]
25. Dynamic contrast-enhanced MRI of the liver in Mrp2-deficient rats using the hepatobiliary contrast agent Gd-EOB-DTPA. Saito S, Obata A, Kashiwagi Y, Abe K, Murase K. Invest Radiol; 2013 Jul 17; 48(7):548-53. PubMed ID: 23442774 [Abstract] [Full Text] [Related]
29. New proposal for the staging of nonalcoholic steatohepatitis: evaluation of liver fibrosis on Gd-EOB-DTPA-enhanced MRI. Tsuda N, Okada M, Murakami T. Eur J Radiol; 2010 Jan 17; 73(1):137-42. PubMed ID: 19026502 [Abstract] [Full Text] [Related]
30. Imaging-Based Staging of Hepatic Fibrosis in Patients with Hepatitis B: A Dynamic Radiomics Model Based on Gd-EOB-DTPA-Enhanced MRI. Zheng R, Shi C, Wang C, Shi N, Qiu T, Chen W, Shi Y, Wang H. Biomolecules; 2021 Feb 18; 11(2):. PubMed ID: 33670596 [Abstract] [Full Text] [Related]
31. [Application of dynamic contrast-enhanced magnetic resonance imaging in evaluating liver fibrosis]. Li XY, Xiong W, Han LJ, Zhang XL, Qiu SJ, Li SL. Nan Fang Yi Ke Da Xue Xue Bao; 2011 Jun 18; 31(7):1259-63. PubMed ID: 21764710 [Abstract] [Full Text] [Related]
37. Development and validation of a predictor of insufficient enhancement during the hepatobiliary phase of Gd-EOB-DTPA-enhanced magnetic resonance imaging. Cui E, Long W, Luo L, Hu M, Huang L, Chen X. Acta Radiol; 2017 Oct 17; 58(10):1174-1181. PubMed ID: 28090793 [Abstract] [Full Text] [Related]
38. Assessing liver function using dynamic Gd-EOB-DTPA-enhanced MRI with a standard 5-phase imaging protocol. Saito K, Ledsam J, Sourbron S, Otaka J, Araki Y, Akata S, Tokuuye K. J Magn Reson Imaging; 2013 May 17; 37(5):1109-14. PubMed ID: 23086736 [Abstract] [Full Text] [Related]
39. Gd-EOB-DTPA-enhanced magnetic resonance imaging features of hepatic hemangioma compared with enhanced computed tomography. Tateyama A, Fukukura Y, Takumi K, Shindo T, Kumagae Y, Kamimura K, Nakajo M. World J Gastroenterol; 2012 Nov 21; 18(43):6269-76. PubMed ID: 23180948 [Abstract] [Full Text] [Related]
40. Gd-EOB-DTPA-enhanced MR relaxometry for the detection and staging of liver fibrosis. Haimerl M, Utpatel K, Verloh N, Zeman F, Fellner C, Nickel D, Teufel A, Fichtner-Feigl S, Evert M, Stroszczynski C, Wiggermann P. Sci Rep; 2017 Jan 27; 7():41429. PubMed ID: 28128291 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]